| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $24.4M | -16.2% |
| Cost of Revenue | $6.4M | +8.1% |
| Gross Profit | $18.0M | -22.4% |
| R&D Expense | $4.7M | +49.0% |
| SG&A Expense | $8.7M | -1.6% |
| Operating Income | -$8.1M | -640.8% |
| Pre-tax Income | -$7.9M | -707.8% |
| Income Tax | $64K | -30.0% |
| Net Income | -$7.9M | -670.0% |
| EPS (Basic) | -$0.14 | -366.7% |
| EPS (Diluted) | -$0.14 | -366.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $15.5M | -26.4% |
| Short-term Investments | $2K | +0.0% |
| Accounts Receivable | $702K | -52.5% |
| Current Assets | $18.1M | -30.2% |
| Total Assets | $31.5M | -10.5% |
| Current Liabilities | $4.8M | -34.7% |
| Total Liabilities | $4.8M | -34.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.1M | -652.6% |
| Capital Expenditures | $65K | +16.3% |
| Investing Cash Flow | -$1.2M | -1734.8% |
| Financing Cash Flow | $2.8M | -20.3% |
| Free Cash Flow | -$7.2M | -617.1% |
| Stockholders' Equity |
| $26.7M |
| -4.2% |